← Back to Search

Med@HOME App for Medication Safety

N/A
Recruiting
Led By Ryan Coller, MD, MPH
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial tests how an app helps caregivers of children w/ medical complexity take medications safely and accurately. 152 caregivers, 152 kids & up to 304 secondary caregivers will be studied for up to 6 months.

Who is the study for?
This trial is for primary caregivers of children with complex medical needs who are under 17, use high-risk medications, and have had multiple healthcare visits in the past year. Caregivers must be over 18, speak English, consent to study rules, and commit to a 6-month participation.Check my eligibility
What is being tested?
The Meds@HOME mobile app is being tested to see if it helps caregivers safely give medication to Children with Medical Complexity (CMC). The study involves up to 456 participants (children and caregivers) using the app over six months.See study design
What are the potential side effects?
Since this trial tests a mobile app designed for medication safety rather than a drug or medical procedure, there aren't typical side effects. However, users may experience stress or frustration if they encounter difficulty using the app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Percentage of Participants Demonstrating Medication Administration Accuracy
Secondary outcome measures
Change in Percentage of Participants Demonstrating Medication Administration Accuracy among Secondary Caregivers
Count of ED encounters during study period
Count of UW Emergency Department (ED) encounters during study period with ADE codes
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Meds@HOME InterventionExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,227 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,044 Total Patients Enrolled
Ryan Coller, MD, MPHPrincipal InvestigatorUniversity of Wisconsin, Madison
3 Previous Clinical Trials
182 Total Patients Enrolled

Media Library

Meds@HOME Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05816590 — N/A
Medication and Product Errors Research Study Groups: Control Group, Meds@HOME Intervention
Medication and Product Errors Clinical Trial 2023: Meds@HOME Intervention Highlights & Side Effects. Trial Name: NCT05816590 — N/A
Meds@HOME Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05816590 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available to participate in this research?

"The details on clinicaltrials.gov reveal that this research is not presently recruiting subjects, as the trial was initially posted in May of 2023 and last modified in April of the same year. Nonetheless, there are 1 other studies currently searching for participants."

Answered by AI
~203 spots leftby May 2025